Back
Matinas BioPharma Holdings Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
38
MTNB
Matinas BioPharma Holdings
Last Price:
0.71
Seasonality Move:
10.35%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing selling pressure, which indicates risk of future bearish movement.
Matinas BioPharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.64 | Buy |
| 20-day SMA: | 2.12 | Sell |
| 50-day SMA: | 2.94 | Sell |
| 200-day SMA: | 0.88 | Sell |
| 8-day EMA: | 0.93 | Sell |
| 20-day EMA: | 1.68 | Sell |
| 50-day EMA: | 2.1 | Sell |
| 200-day EMA: | 1.23 | Sell |
Matinas BioPharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 24.37 | Sell |
| Chaikin Money Flow: | -267916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.01 - 3.67) | Sell |
| Bollinger Bands (100): | (-0.07 - 3.15) | Sell |
Matinas BioPharma Holdings Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Matinas BioPharma Holdings Stock
Is Matinas BioPharma Holdings Stock a Buy?
- Matinas BioPharma Holdings share price is 0.75 while MTNB 8-day simple moving average is 0.64, which is a Buy signal.
- The stock price of MTNB is 0.75 while Matinas BioPharma Holdings 20-day SMA is 2.12, which makes it a Sell.
- Matinas BioPharma Holdings 50-day simple moving average is 2.94 while MTNB share price is 0.75, making it a Sell technically.
- MTNB stock price is 0.75 and Matinas BioPharma Holdings 200-day simple moving average is 0.88, creating a Sell signal.
MTNB Technical Analysis vs Fundamental Analysis
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy or a Sell?
-
Matinas BioPharma Holdings stock is rated a Sell
The current Matinas BioPharma Holdings [MTNB] share price is $0.75. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Matinas BioPharma Holdings Stock Info
Market Cap:
3.74M
Price in USD:
0.75
Share Volume:
442.17K
Matinas BioPharma Holdings 52-Week Range
52-Week High:
21.50
52-Week Low:
0.50
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Matinas BioPharma Holdings Share Price Forecast
-
What is the Matinas BioPharma Holdings stock price today?
The Matinas BioPharma Holdings stock price is 0.75 USD today. -
Will MTNB stock go up or go down?
Matinas BioPharma Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Matinas BioPharma Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Matinas BioPharma Holdings is overvalued.
Is Matinas BioPharma Holdings Stock a Buy?
- Matinas BioPharma Holdings share price is 0.75 while MTNB 8-day exponential moving average is 0.93, which is a Sell signal.
- The stock price of MTNB is 0.75 while Matinas BioPharma Holdings 20-day EMA is 1.68, which makes it a Sell.
- Matinas BioPharma Holdings 50-day exponential moving average is 2.10 while MTNB share price is 0.75, making it a Sell technically.
- MTNB stock price is 0.75 and Matinas BioPharma Holdings 200-day simple moving average is 1.23, creating a Sell signal.
Fundamental Analysis of Matinas BioPharma Holdings
Is Matinas BioPharma Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.15 per share, and an increase next year of $1.35 per share.
Technical Analysis of Matinas BioPharma Holdings
Should I short Matinas BioPharma Holdings stock?
- MTNB Moving Average Covergence Divergence (MACD) indicator is -0.68, suggesting Matinas BioPharma Holdings is a Sell
- Matinas BioPharma Holdings Relative Strength Index (RSI) is 24.37, which suggest Matinas BioPharma Holdings is oversold
- The Bollinger Bands (25) for Matinas BioPharma Holdings is (1.01 - 3.67), which suggest Matinas BioPharma Holdings is a Sell
- The Bollinger Bands (100) for Matinas BioPharma Holdings is (-0.07 - 3.15), which suggest Matinas BioPharma Holdings is a Sell
* Matinas BioPharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.